Literature DB >> 23394681

Anti-idiotypic monobodies derived from a fibronectin scaffold.

Mark A Sullivan1, Lauren R Brooks, Philip Weidenborner, William Domm, Jonelle Mattiacio, Qingfu Xu, Michael Tiberio, Timothy Wentworth, James Kobie, Peter Bryk, Bo Zheng, Mary Murphy, Ignacio Sanz, Stephen Dewhurst.   

Abstract

Mimetics of conformational protein epitopes have broad applications but have been difficult to identify using conventional peptide phage display. The 10th type III domain of human fibronectin (FNfn10) has two extended, randomizable surface-exposed loops and might be more amenable to the identification of such mimetics. We therefore selected a library of FNfn10 clones, randomized in both loops (15 residues in all), for binding to monoclonal antibodies (mAbs) that recognize the HIV-1 envelope glycoprotein. Anti-idiotypic monobodies (αIMs) mimicking both "linear" epitopes (2F5 and 4E10 mAbs) and conformational epitopes (b12 and VRC01 mAbs) were generated. αIMs selected against 2F5 and 4E10 frequently displayed sequence homology to the corresponding linear native epitopes. In the case of b12 and VRC01, we expected that the two constrained loop domains of FNfn10 would both contribute to complex conformational interactions with target antibodies. However, mutagenesis studies revealed differences from this simple model. An αIM selected against b12 was found to bind its cognate antibody via only a few residues within the BC loop of FNfn10, with minimal contribution from the FG loop. Unexpectedly, this was sufficient to generate a protein that engaged its cognate antibody in a manner very similar to that of HIV-1 Env, and with a strong KD (43 nM). In contrast, an αIM selected against VRC01 engaged its cognate antibody in a manner that was dependent on both BC and FG loop sequences. Overall, these data suggest that the FNfn10 scaffold can be used to identify complex structures that mimic conformational protein epitopes.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23394681      PMCID: PMC4090420          DOI: 10.1021/bi3016668

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  55 in total

1.  Rapid mapping of protein functional epitopes by combinatorial alanine scanning.

Authors:  G A Weiss; C K Watanabe; A Zhong; A Goddard; S S Sidhu
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

2.  Selection of large diversities of antiidiotypic antibody fragments by phage display.

Authors:  Steffen Goletz; Peter Astrup Christensen; Peter Kristensen; Dietmar Blohm; Ian Tomlinson; Greg Winter; Uwe Karsten
Journal:  J Mol Biol       Date:  2002-02-01       Impact factor: 5.469

3.  Immunogenically fit subunit vaccine components via epitope discovery from natural peptide libraries.

Authors:  Leslie J Matthews; Robert Davis; George P Smith
Journal:  J Immunol       Date:  2002-07-15       Impact factor: 5.422

4.  Evaluation of semi-homogeneous assay formats for dual-specificity antibodies.

Authors:  Guoying Jiang; Chung W Lee; Pin Yee Wong; Hélène Gazzano-Santoro
Journal:  J Immunol Methods       Date:  2012-10-09       Impact factor: 2.303

5.  Identification and characterization of a peptide that specifically binds the human, broadly neutralizing anti-human immunodeficiency virus type 1 antibody b12.

Authors:  M B Zwick; L L Bonnycastle; A Menendez; M B Irving; C F Barbas; P W Parren; D R Burton; J K Scott
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

6.  Rapid and efficient site-specific mutagenesis without phenotypic selection.

Authors:  T A Kunkel; J D Roberts; R A Zakour
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

7.  A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1.

Authors:  G Stiegler; R Kunert; M Purtscher; S Wolbank; R Voglauer; F Steindl; H Katinger
Journal:  AIDS Res Hum Retroviruses       Date:  2001-12-10       Impact factor: 2.205

8.  Molecular features of the broadly neutralizing immunoglobulin G1 b12 required for recognition of human immunodeficiency virus type 1 gp120.

Authors:  Michael B Zwick; Paul W H I Parren; Erica O Saphire; Sarah Church; Meng Wang; Jamie K Scott; Philip E Dawson; Ian A Wilson; Dennis R Burton
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

9.  Engineered fibronectin type III domain with a RGDWXE sequence binds with enhanced affinity and specificity to human alphavbeta3 integrin.

Authors:  Julie Richards; Michelle Miller; Johanna Abend; Akiko Koide; Shohei Koide; Stephen Dewhurst
Journal:  J Mol Biol       Date:  2003-03-07       Impact factor: 5.469

10.  Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41.

Authors:  M B Zwick; A F Labrijn; M Wang; C Spenlehauer; E O Saphire; J M Binley; J P Moore; G Stiegler; H Katinger; D R Burton; P W Parren
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

View more
  7 in total

Review 1.  Beyond Antibodies as Binding Partners: The Role of Antibody Mimetics in Bioanalysis.

Authors:  Xiaowen Yu; Yu-Ping Yang; Emre Dikici; Sapna K Deo; Sylvia Daunert
Journal:  Annu Rev Anal Chem (Palo Alto Calif)       Date:  2017-03-24       Impact factor: 10.745

2.  An Engineered Pathway for Production of Terminally Sialylated N-glycoproteins in the Periplasm of Escherichia coli.

Authors:  Jing Zhu; Yao Ruan; Xin Fu; Lichao Zhang; Gaoshun Ge; J Gerard Wall; Teng Zou; Yang Zheng; Ning Ding; Xuejun Hu
Journal:  Front Bioeng Biotechnol       Date:  2020-04-15

Review 3.  Opportunities and Challenges for Antibodies against Intracellular Antigens.

Authors:  Xiaofeng Yang; Shenxia Xie; Xiaomei Yang; Juan C Cueva; Xiaoqiong Hou; Zhuoran Tang; Hua Yao; Fengzhen Mo; Shihua Yin; Aiqun Liu; Xiaoling Lu
Journal:  Theranostics       Date:  2019-10-15       Impact factor: 11.556

4.  High-Throughput Ligand Discovery Reveals a Sitewise Gradient of Diversity in Broadly Evolved Hydrophilic Fibronectin Domains.

Authors:  Daniel R Woldring; Patrick V Holec; Hong Zhou; Benjamin J Hackel
Journal:  PLoS One       Date:  2015-09-18       Impact factor: 3.240

5.  Semi-synthetic vNAR libraries screened against therapeutic antibodies primarily deliver anti-idiotypic binders.

Authors:  Doreen Könning; Laura Rhiel; Martin Empting; Julius Grzeschik; Carolin Sellmann; Christian Schröter; Stefan Zielonka; Stephan Dickgießer; Thomas Pirzer; Desislava Yanakieva; Stefan Becker; Harald Kolmar
Journal:  Sci Rep       Date:  2017-08-29       Impact factor: 4.379

6.  Display of the HIV envelope protein at the yeast cell surface for immunogen development.

Authors:  Elizabeth Mathew; Hong Zhu; Sara M Connelly; Mark A Sullivan; Matthew G Brewer; Michael S Piepenbrink; James J Kobie; Stephen Dewhurst; Mark E Dumont
Journal:  PLoS One       Date:  2018-10-18       Impact factor: 3.240

7.  Identification of variant HIV envelope proteins with enhanced affinities for precursors to anti-gp41 broadly neutralizing antibodies.

Authors:  Hong Zhu; Elizabeth Mathew; Sara M Connelly; Jeffrey Zuber; Mark Sullivan; Michael S Piepenbrink; James J Kobie; Mark E Dumont
Journal:  PLoS One       Date:  2019-09-10       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.